Cardiol Therapeutics Inc
TSX:CRDL

Watchlist Manager
Cardiol Therapeutics Inc Logo
Cardiol Therapeutics Inc
TSX:CRDL
Watchlist
Price: 1.82 CAD -2.67%
Market Cap: 148.5m CAD
Have any thoughts about
Cardiol Therapeutics Inc?
Write Note

Income Statement

Earnings Waterfall
Cardiol Therapeutics Inc

Revenue
0 CAD
Operating Expenses
-38.3m CAD
Operating Income
-38.3m CAD
Other Expenses
2.2m CAD
Net Income
-36.1m CAD

Income Statement
Cardiol Therapeutics Inc

Rotate your device to view
Income Statement
Currency: CAD
Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(3)
(5)
(7)
(10)
(13)
(14)
(14)
(14)
(14)
(14)
(21)
(27)
(30)
(35)
(39)
(40)
(42)
(45)
(41)
(39)
(36)
(31)
(30)
(30)
(32)
(38)
Selling, General & Administrative
(2)
(3)
(5)
(8)
(10)
(11)
(10)
(10)
(10)
(10)
(10)
(14)
(15)
(21)
(28)
(27)
(28)
(28)
(22)
(20)
(18)
(15)
(15)
(17)
(19)
(24)
Research & Development
(1)
(1)
(2)
(2)
(2)
(3)
(4)
(4)
(4)
(4)
(11)
(13)
(14)
(15)
(11)
(12)
(14)
(17)
(19)
(19)
(18)
(16)
(14)
(13)
(13)
(14)
Depreciation & Amortization
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Operating Income
(3)
N/A
(5)
-67%
(7)
-49%
(10)
-47%
(13)
-24%
(14)
-9%
(14)
0%
(14)
+3%
(14)
+1%
(14)
-6%
(21)
-44%
(27)
-29%
(29)
-11%
(35)
-20%
(39)
-10%
(39)
-2%
(42)
-7%
(45)
-7%
(41)
+9%
(39)
+5%
(36)
+7%
(31)
+15%
(30)
+3%
(30)
-2%
(32)
-5%
(38)
-20%
Pre-Tax Income
Interest Income Expense
(0)
(3)
(8)
(8)
(8)
(6)
0
0
0
0
0
(0)
(0)
0
7
8
11
15
10
10
6
3
2
0
2
2
Non-Reccuring Items
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Pre-Tax Income
(3)
N/A
(7)
-144%
(16)
-114%
(19)
-19%
(21)
-12%
(20)
+7%
(14)
+31%
(13)
+4%
(13)
+0%
(14)
-7%
(21)
-47%
(27)
-29%
(30)
-11%
(35)
-19%
(32)
+10%
(32)
0%
(32)
+0%
(30)
+6%
(31)
-4%
(29)
+6%
(30)
-3%
(28)
+7%
(28)
0%
(30)
-7%
(29)
+3%
(36)
-23%
Net Income
Tax Provision
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Income from Continuing Operations
(3)
(7)
(16)
(19)
(21)
(20)
(14)
(13)
(13)
(14)
(21)
(27)
(30)
(35)
(32)
(32)
(32)
(30)
(31)
(29)
(30)
(28)
(28)
(30)
(29)
(36)
Net Income (Common)
(3)
N/A
(7)
-144%
(16)
-114%
(19)
-19%
(21)
-12%
(20)
+7%
(14)
+31%
(13)
+4%
(13)
+0%
(14)
-7%
(21)
-47%
(27)
-29%
(30)
-11%
(35)
-19%
(32)
+10%
(32)
0%
(32)
+0%
(30)
+6%
(31)
-4%
(29)
+6%
(30)
-3%
(28)
+7%
(28)
0%
(30)
-7%
(29)
+3%
(36)
-23%
EPS (Diluted)
-0.2
N/A
-0.32
-60%
-0.62
-94%
-0.73
-18%
-0.81
-11%
-0.76
+6%
-0.53
+30%
-0.5
+6%
-0.49
+2%
-0.42
+14%
-0.69
-64%
-0.76
-10%
-0.61
+20%
-0.81
-33%
-0.73
+10%
-0.51
+30%
-0.51
N/A
-0.48
+6%
-0.49
-2%
-0.46
+6%
-0.48
-4%
-0.44
+8%
-0.44
N/A
-0.46
-5%
-0.44
+4%
-0.53
-20%

See Also

Discover More